Syneos Health Reports Third Quarter 2021 Results
November 03, 2021 06:16 ET
|
Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...
Syneos Health Reports Second Quarter 2021 Results
August 09, 2021 06:12 ET
|
Syneos Health, Inc.
Highlights Second quarter revenue of $1,282.6 million, increased 6.1% sequentially and 26.6% year-over-year.Clinical Solutions net new business awards of $1,436.2 million for the second quarter,...
Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent
March 15, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...
Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution
March 27, 2018 07:05 ET
|
Syneos Health
RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding...
INC Research/inVentiv Health Schedules Third Quarter 2017 Earnings Call for Thursday, November 9, 2017
October 19, 2017 17:02 ET
|
INC Research, LLC
RALEIGH, N.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
INC Research and inVentiv Health Announce Successful Completion of Merger
August 01, 2017 09:12 ET
|
INC Research, LLC
Combination Creates the Only Fully Integrated Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3 Billion Relaunch Under New Brand Planned for 2018 RALEIGH, N.C. and...
INC Research and inVentiv Health to Merge
May 10, 2017 06:03 ET
|
INC Research, LLC
Creates a Leading Global Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3.2 Billion Combined Company Will Be Second Largest Biopharmaceutical Outsourcing Provider,...
INC Research is the First CRO to obtain IAOCR’s Silver Workforce Quality Accreditation Status
April 25, 2017 10:00 ET
|
INC Research, LLC
RALEIGH, N.C., April 25, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, and IAOCR, the accrediting organization...
INC Research Ranked “Top CRO to Work With” Among Top 10 Global CROs for Third Consecutive Time in Biannual CenterWatch Survey
April 03, 2017 07:47 ET
|
INC Research, LLC
Survey ranking reinforces Company’s industry-leading position as CRO of Choice for sitesOnly company to rank consistently among top three CROs in every survey over the last decadeCompany rated a top...
INC Research Strengthens Real World & Late Phase and Global Consulting Capabilities with Key Leadership Appointments
March 30, 2017 12:51 ET
|
INC Research, LLC
Additional senior-level expertise enhances global CRO’s strategic services offering, helping large pharma to meet their commercial objectives while strongly positioning the Company to capitalize...